Pivotal bioVenture Partners
Thesis
Therapeutics-focused life sciences VC backing North American and European drug developers from formation to commercialization.
Stages
GrowthSeedSeries ASeries BSeries C
Sectors
BiotechHealthcare/MedtechLife SciencesDeep Tech/Hard ScienceAI/ML
Fund
- Current fund
- Pivotal bioVenture Partners Fund II · 2023 · $$389M
- AUM
- $$689M+